annual EBITDA:
-$82.33M-$42.46M(-106.50%)Summary
- As of today (July 2, 2025), BCAX annual EBITDA is -$82.33 million, with the most recent change of -$42.46 million (-106.50%) on December 31, 2024.
- During the last 3 years, BCAX annual EBITDA has fallen by -$44.61 million (-118.26%).
- BCAX annual EBITDA is now -118.26% below its all-time high of -$37.72 million, reached on December 31, 2022.
Performance
BCAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$41.77M-$15.15M(-56.90%)Summary
- As of today (July 2, 2025), BCAX quarterly EBITDA is -$41.77 million, with the most recent change of -$15.15 million (-56.90%) on March 31, 2025.
- Over the past year, BCAX quarterly EBITDA has dropped by -$26.41 million (-171.92%).
- BCAX quarterly EBITDA is now -338.38% below its all-time high of -$9.53 million, reached on September 1, 2023.
Performance
BCAX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$108.74M-$26.41M(-32.07%)Summary
- As of today (July 2, 2025), BCAX TTM EBITDA is -$108.74 million, with the most recent change of -$26.41 million (-32.07%) on March 31, 2025.
- Over the past year, BCAX TTM EBITDA has dropped by -$70.18 million (-181.99%).
- BCAX TTM EBITDA is now -1041.28% below its all-time high of -$9.53 million, reached on September 1, 2023.
Performance
BCAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BCAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.5% | -171.9% | -182.0% |
| 3 y3 years | -118.3% | -338.4% | -1041.3% |
| 5 y5 years | -118.3% | -338.4% | -1041.3% |
BCAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -118.3% | at low | -338.4% | at low | -1041.3% | at low |
| 5 y | 5-year | -118.3% | at low | -338.4% | at low | -1041.3% | at low |
| alltime | all time | -118.3% | at low | -338.4% | at low | -1041.3% | at low |
BCAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$41.77M(+56.9%) | -$108.74M(+32.1%) |
| Dec 2024 | -$82.33M | -$26.62M(+29.2%) | -$82.33M(+18.7%) |
| Sep 2024 | - | -$20.61M(+4.4%) | -$69.38M(+19.0%) |
| Jun 2024 | - | -$19.74M(+28.5%) | -$58.30M(+51.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$15.36M(+12.3%) | -$38.56M(+66.2%) |
| Dec 2023 | -$39.87M(+5.7%) | -$13.67M(+43.5%) | -$23.20M(+143.5%) |
| Sep 2023 | - | -$9.53M | -$9.53M |
| Dec 2022 | -$37.72M | - | - |
FAQ
- What is Bicara Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics annual EBITDA year-on-year change?
- What is Bicara Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly EBITDA year-on-year change?
- What is Bicara Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Bicara Therapeutics?
- What is Bicara Therapeutics TTM EBITDA year-on-year change?
What is Bicara Therapeutics annual EBITDA?
The current annual EBITDA of BCAX is -$82.33M
What is the all time high annual EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high annual EBITDA is -$37.72M
What is Bicara Therapeutics annual EBITDA year-on-year change?
Over the past year, BCAX annual EBITDA has changed by -$42.46M (-106.50%)
What is Bicara Therapeutics quarterly EBITDA?
The current quarterly EBITDA of BCAX is -$41.77M
What is the all time high quarterly EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly EBITDA is -$9.53M
What is Bicara Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BCAX quarterly EBITDA has changed by -$26.41M (-171.92%)
What is Bicara Therapeutics TTM EBITDA?
The current TTM EBITDA of BCAX is -$108.74M
What is the all time high TTM EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM EBITDA is -$9.53M
What is Bicara Therapeutics TTM EBITDA year-on-year change?
Over the past year, BCAX TTM EBITDA has changed by -$70.18M (-181.99%)